L
Linden T. Hu
Researcher at Tufts University
Publications - 92
Citations - 4551
Linden T. Hu is an academic researcher from Tufts University. The author has contributed to research in topics: Borrelia burgdorferi & Lyme disease. The author has an hindex of 36, co-authored 86 publications receiving 3938 citations. Previous affiliations of Linden T. Hu include Tufts Medical Center & Boston University.
Papers
More filters
Journal ArticleDOI
Of ticks, mice and men: understanding the dual-host lifestyle of Lyme disease spirochaetes
TL;DR: This Review integrates a large body of information on the phylogenetic diversity, molecular biology, genetics and host interactions of B. burgdorferi into a cohesive picture of the molecular and cellular events that transpire as Lyme disease spirochaetes transit between their arthropod and vertebrate hosts during the enzootic cycle.
Journal ArticleDOI
Two Controlled Trials of Antibiotic Treatment in Patients with Persistent Symptoms and a History of Lyme Disease
Mark S. Klempner,Linden T. Hu,Janine Evans,Christopher H. Schmid,Gary M. Johnson,Richard P. Trevino,Delona Norton,Lois Levy,Diane Wall,John McCall,Mark Kosinski,Arthur Weinstein +11 more
TL;DR: There is considerable impairment of health-related quality of life among patients with persistent symptoms despite previous antibiotic treatment for acute Lyme disease, and treatment with intravenous and oral antibiotics for 90 days did not improve symptoms more than placebo.
Journal ArticleDOI
Diagnosis, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis: A Review
TL;DR: Evidence supports the use of US Food and Drug Administration-approved serologic tests, such as an enzyme immunoassay (EIA), followed by Western blot testing, to diagnose extracutaneous manifestations of Lyme disease.
Journal ArticleDOI
Septic arthritis of the pubic symphysis: review of 100 cases.
John J. Ross,Linden T. Hu +1 more
TL;DR: A novel case of septic arthritis of the symphysis pubis due to Streptococcus pneumoniae is reported and antibiotic courses of 6 weeks’ duration are recommended, since osteomyelitis is present in 97% of patients.
Journal ArticleDOI
Borrelia burgdorferi, the causative agent of Lyme disease, forms drug-tolerant persister cells.
TL;DR: Killing growing cultures of B. burgdorferi with antibiotics used to treat the disease was distinctly biphasic, with a small subpopulation of surviving cells, indicating that these are persisters rather than resistant mutants, and pulse dosing an antibiotic to eliminate persisters was examined.